Cargando…
The Utility of Specific Antibodies Against SARS-CoV-2 in Laboratory Diagnosis
The Coronavirus Disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has now become a global pandemic due to its high transmissibility. The unavoidable shortcomings of traditional diagnostic assay, including nucleic acid testing, diverse serological assa...
Autores principales: | Fu, Yu, Pan, Yunbao, Li, Zhiqiang, Li, Yirong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838213/ https://www.ncbi.nlm.nih.gov/pubmed/33519745 http://dx.doi.org/10.3389/fmicb.2020.603058 |
Ejemplares similares
-
Re: Profile of specific antibodies to SARS-CoV-2: The first report
por: Zeng, Zhikun, et al.
Publicado: (2020) -
The utility of SARS‐CoV‐2 nucleocapsid protein in laboratory diagnosis
por: Li, Xinwei, et al.
Publicado: (2022) -
High Performance of SARS-Cov-2N Protein Antigen Chemiluminescence Immunoassay as Frontline Testing for Acute Phase COVID-19 Diagnosis: A Retrospective Cohort Study
por: Deng, Qiaoling, et al.
Publicado: (2021) -
Profile of specific antibodies to the SARS-CoV-2
por: Mou, Danlei, et al.
Publicado: (2021) -
Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients
por: Pan, Yunbao, et al.
Publicado: (2020)